# Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Source: https://onco.cc/trials/nct04645160/  
OnCo record `nct04645160` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of tivozanib in gallbladder cancer and other biliary tract cancers, run by National Cancer Institute (NCI), now recruiting.

## Summary

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers is a phase 1/2 interventional study registered as NCT04645160 by National Cancer Institute (NCI), with a registry enrolment figure of 31 participants, started 2022-03-04 and due to reach its primary completion in 2028-12-31. Interventions recorded: Tivozanib. Conditions listed: Cholangiocarcinoma, Bile Duct Neoplasm, Biliary Tract Malignancy. Gallbladder cancer is named in the registry entry: "1. Participants with histologically or cytologically confirmed biliary tract cancer (BTC) (cholangiocarcinoma or gallbladder cancer). Archival tumor sample may be used but if archival tissue is not available or is not ad". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT04645160
- Phase: 1/2
- Setting: Phase II Study Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
- Sponsor: National Cancer Institute (NCI)
- Enrolled: 31

## Sources

- ClinicalTrials.gov NCT04645160: https://clinicaltrials.gov/study/NCT04645160

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Tivozanib](https://onco.cc/drugs/tivozanib/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct04645160.json